共 30 条
Bortezomib and gemcitabine in relapsed or refractory Hodgkin's lymphoma
被引:27
作者:

Mendler, J. H.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Dept Internal Med, Rochester, NY 14642 USA Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Dept Internal Med, Rochester, NY 14642 USA

Kelly, J.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Dept Internal Med, Rochester, NY 14642 USA Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Dept Internal Med, Rochester, NY 14642 USA

Voci, S.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Dept Internal Med, Rochester, NY 14642 USA Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Dept Internal Med, Rochester, NY 14642 USA

Marquis, D.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Dept Internal Med, Rochester, NY 14642 USA Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Dept Internal Med, Rochester, NY 14642 USA

Rich, L.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Dept Internal Med, Rochester, NY 14642 USA Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Dept Internal Med, Rochester, NY 14642 USA

Rossi, R. M.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Dept Internal Med, Rochester, NY 14642 USA Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Dept Internal Med, Rochester, NY 14642 USA

Bernstein, S. H.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Dept Internal Med, Rochester, NY 14642 USA Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Dept Internal Med, Rochester, NY 14642 USA

Jordan, C. T.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Dept Internal Med, Rochester, NY 14642 USA Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Dept Internal Med, Rochester, NY 14642 USA

Liesveld, J.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Dept Internal Med, Rochester, NY 14642 USA Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Dept Internal Med, Rochester, NY 14642 USA

Fisher, R. I.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Dept Internal Med, Rochester, NY 14642 USA Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Dept Internal Med, Rochester, NY 14642 USA

Friedberg, J. W.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Dept Internal Med, Rochester, NY 14642 USA Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Dept Internal Med, Rochester, NY 14642 USA
机构:
[1] Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Dept Internal Med, Rochester, NY 14642 USA
关键词:
bortezomib;
gemcitabine;
hepatotoxicity;
Hodgkin's lymphoma;
proteasome;
relapsed;
D O I:
10.1093/annonc/mdn365
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Background: Given the significant activity and tolerability of gemcitabine in patients with relapsed Hodgkin's lymphoma (HL), the critical role that nuclear factor kappa B (NF-kappa B) appears to play in the pathogenesis of this tumor, the ability of bortezomib to inhibit NF-kappa B activity, and laboratory studies suggesting synergistic antitumor effects of gemcitabine and bortezomib, we hypothesized that this combination would be efficacious in patients with relapsed or refractory HL. Patients and methods: A total of 18 patients participated. Patients received 3-week cycles of bortezomib 1 mg/m(2) on days 1, 4, 8, and 11 plus gemcitabine 800 mg/m(2) on days 1 and 8. Results: The overall response rate for all patients was 22% (95% confidence interval 3% to 42%). Three patients developed grade III transaminase elevation: one was removed from the study and two had doses of gemcitabine held. Almost all patients exhibited inhibition of proteasome activity with treatment. Conclusions: The combination of gemcitabine and bortezomib is a less active and more toxic regimen in relapsed HL than other currently available treatments. It poses a risk of severe liver toxicity and should be pursued with caution in other types of cancer.
引用
收藏
页码:1759 / 1764
页数:6
相关论文
共 30 条
[1]
PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group (NCCTG) randomized phase II study
[J].
Alberts, SR
;
Foster, NR
;
Morton, RF
;
Kugler, J
;
Schaefer, P
;
Wiesenfeld, M
;
Fitch, TR
;
Steen, P
;
Kim, GP
;
Gill, S
.
ANNALS OF ONCOLOGY,
2005, 16 (10)
:1654-1661

Alberts, SR
论文数: 0 引用数: 0
h-index: 0
机构: Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA

Foster, NR
论文数: 0 引用数: 0
h-index: 0
机构: Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA

Morton, RF
论文数: 0 引用数: 0
h-index: 0
机构: Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA

Kugler, J
论文数: 0 引用数: 0
h-index: 0
机构: Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA

Schaefer, P
论文数: 0 引用数: 0
h-index: 0
机构: Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA

Wiesenfeld, M
论文数: 0 引用数: 0
h-index: 0
机构: Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA

Fitch, TR
论文数: 0 引用数: 0
h-index: 0
机构: Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA

Steen, P
论文数: 0 引用数: 0
h-index: 0
机构: Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA

Kim, GP
论文数: 0 引用数: 0
h-index: 0
机构: Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA

Gill, S
论文数: 0 引用数: 0
h-index: 0
机构: Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA
[2]
Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804
[J].
Bartlett, N. L.
;
Niedzwiecki, D.
;
Johnson, J. L.
;
Friedberg, J. W.
;
Johnson, K. B.
;
van Besien, K.
;
Zelenetz, A. D.
;
Cheson, B. D.
;
Canellos, G. P.
.
ANNALS OF ONCOLOGY,
2007, 18 (06)
:1071-1079

Bartlett, N. L.
论文数: 0 引用数: 0
h-index: 0
机构: Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63110 USA

Niedzwiecki, D.
论文数: 0 引用数: 0
h-index: 0
机构: Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63110 USA

Johnson, J. L.
论文数: 0 引用数: 0
h-index: 0
机构: Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63110 USA

Friedberg, J. W.
论文数: 0 引用数: 0
h-index: 0
机构: Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63110 USA

Johnson, K. B.
论文数: 0 引用数: 0
h-index: 0
机构: Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63110 USA

van Besien, K.
论文数: 0 引用数: 0
h-index: 0
机构: Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63110 USA

Zelenetz, A. D.
论文数: 0 引用数: 0
h-index: 0
机构: Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63110 USA

Cheson, B. D.
论文数: 0 引用数: 0
h-index: 0
机构: Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63110 USA

Canellos, G. P.
论文数: 0 引用数: 0
h-index: 0
机构: Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63110 USA
[3]
Single agent bortezomib in the treatment of relapsed and refractory Hodgkin lymphoma: Cancer and leukemia Group B protocol 50206
[J].
Blum, Kristie A.
;
Johnson, Jeffrey L.
;
Niedzwiecki, Donna
;
Canellos, George P.
;
Cheson, Bruce D.
;
Bartlett, Nancy L.
.
LEUKEMIA & LYMPHOMA,
2007, 48 (07)
:1313-1319

Blum, Kristie A.
论文数: 0 引用数: 0
h-index: 0
机构: Ohio State Univ, Dept Internal Med, Div Haematol Oncol, Columbus, OH 43210 USA

Johnson, Jeffrey L.
论文数: 0 引用数: 0
h-index: 0
机构: Ohio State Univ, Dept Internal Med, Div Haematol Oncol, Columbus, OH 43210 USA

Niedzwiecki, Donna
论文数: 0 引用数: 0
h-index: 0
机构: Ohio State Univ, Dept Internal Med, Div Haematol Oncol, Columbus, OH 43210 USA

Canellos, George P.
论文数: 0 引用数: 0
h-index: 0
机构: Ohio State Univ, Dept Internal Med, Div Haematol Oncol, Columbus, OH 43210 USA

Cheson, Bruce D.
论文数: 0 引用数: 0
h-index: 0
机构: Ohio State Univ, Dept Internal Med, Div Haematol Oncol, Columbus, OH 43210 USA

Bartlett, Nancy L.
论文数: 0 引用数: 0
h-index: 0
机构: Ohio State Univ, Dept Internal Med, Div Haematol Oncol, Columbus, OH 43210 USA
[4]
Chemosensitization of pancreatic cancer by inhibition of the 26S proteasome
[J].
Bold, RJ
;
Virudachalam, S
;
McConkey, DJ
.
JOURNAL OF SURGICAL RESEARCH,
2001, 100 (01)
:11-17

Bold, RJ
论文数: 0 引用数: 0
h-index: 0
机构: Univ Calif Davis, Ctr Canc, Med Ctr, Dept Surg,Div Surg Oncol, Sacramento, CA 95817 USA

Virudachalam, S
论文数: 0 引用数: 0
h-index: 0
机构: Univ Calif Davis, Ctr Canc, Med Ctr, Dept Surg,Div Surg Oncol, Sacramento, CA 95817 USA

McConkey, DJ
论文数: 0 引用数: 0
h-index: 0
机构: Univ Calif Davis, Ctr Canc, Med Ctr, Dept Surg,Div Surg Oncol, Sacramento, CA 95817 USA
[5]
The fully human anti-CD30 antibody 5F11 activates NF-κB and sensitizes lymphoma cells to bortezomib-induced apoptosis
[J].
Böll, B
;
Hansen, H
;
Heuck, F
;
Reiners, K
;
Borchmann, P
;
Rothe, A
;
Engert, A
;
von Strandmann, EP
.
BLOOD,
2005, 106 (05)
:1839-1842

Böll, B
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Hosp Cologne, Dept Internal Med 1, Lab Immunotherapy, D-50924 Cologne, Germany Univ Hosp Cologne, Dept Internal Med 1, Lab Immunotherapy, D-50924 Cologne, Germany

Hansen, H
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Hosp Cologne, Dept Internal Med 1, Lab Immunotherapy, D-50924 Cologne, Germany Univ Hosp Cologne, Dept Internal Med 1, Lab Immunotherapy, D-50924 Cologne, Germany

Heuck, F
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Hosp Cologne, Dept Internal Med 1, Lab Immunotherapy, D-50924 Cologne, Germany Univ Hosp Cologne, Dept Internal Med 1, Lab Immunotherapy, D-50924 Cologne, Germany

Reiners, K
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Hosp Cologne, Dept Internal Med 1, Lab Immunotherapy, D-50924 Cologne, Germany Univ Hosp Cologne, Dept Internal Med 1, Lab Immunotherapy, D-50924 Cologne, Germany

Borchmann, P
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Hosp Cologne, Dept Internal Med 1, Lab Immunotherapy, D-50924 Cologne, Germany Univ Hosp Cologne, Dept Internal Med 1, Lab Immunotherapy, D-50924 Cologne, Germany

Rothe, A
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Hosp Cologne, Dept Internal Med 1, Lab Immunotherapy, D-50924 Cologne, Germany Univ Hosp Cologne, Dept Internal Med 1, Lab Immunotherapy, D-50924 Cologne, Germany

Engert, A
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Hosp Cologne, Dept Internal Med 1, Lab Immunotherapy, D-50924 Cologne, Germany Univ Hosp Cologne, Dept Internal Med 1, Lab Immunotherapy, D-50924 Cologne, Germany

von Strandmann, EP
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Hosp Cologne, Dept Internal Med 1, Lab Immunotherapy, D-50924 Cologne, Germany Univ Hosp Cologne, Dept Internal Med 1, Lab Immunotherapy, D-50924 Cologne, Germany
[6]
Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas
[J].
Cheson, BD
;
Horning, SJ
;
Coiffier, B
;
Shipp, MA
;
Fisher, RI
;
Connors, JM
;
Lister, TA
;
Vose, J
;
Grillo-López, A
;
Hagenbeek, A
;
Cabanillas, F
;
Klippensten, D
;
Hiddemann, W
;
Castellino, R
;
Harris, NL
;
Armitage, JO
;
Carter, W
;
Hoppe, R
;
Canellos, GP
.
JOURNAL OF CLINICAL ONCOLOGY,
1999, 17 (04)
:1244-1253

Cheson, BD
论文数: 0 引用数: 0
h-index: 0
机构: NCI, Bethesda, MD 20892 USA

Horning, SJ
论文数: 0 引用数: 0
h-index: 0
机构: NCI, Bethesda, MD 20892 USA

Coiffier, B
论文数: 0 引用数: 0
h-index: 0
机构: NCI, Bethesda, MD 20892 USA

Shipp, MA
论文数: 0 引用数: 0
h-index: 0
机构: NCI, Bethesda, MD 20892 USA

Fisher, RI
论文数: 0 引用数: 0
h-index: 0
机构: NCI, Bethesda, MD 20892 USA

Connors, JM
论文数: 0 引用数: 0
h-index: 0
机构: NCI, Bethesda, MD 20892 USA

Lister, TA
论文数: 0 引用数: 0
h-index: 0
机构: NCI, Bethesda, MD 20892 USA

Vose, J
论文数: 0 引用数: 0
h-index: 0
机构: NCI, Bethesda, MD 20892 USA

Grillo-López, A
论文数: 0 引用数: 0
h-index: 0
机构: NCI, Bethesda, MD 20892 USA

Hagenbeek, A
论文数: 0 引用数: 0
h-index: 0
机构: NCI, Bethesda, MD 20892 USA

Cabanillas, F
论文数: 0 引用数: 0
h-index: 0
机构: NCI, Bethesda, MD 20892 USA

Klippensten, D
论文数: 0 引用数: 0
h-index: 0
机构: NCI, Bethesda, MD 20892 USA

Hiddemann, W
论文数: 0 引用数: 0
h-index: 0
机构: NCI, Bethesda, MD 20892 USA

Castellino, R
论文数: 0 引用数: 0
h-index: 0
机构: NCI, Bethesda, MD 20892 USA

Harris, NL
论文数: 0 引用数: 0
h-index: 0
机构: NCI, Bethesda, MD 20892 USA

Armitage, JO
论文数: 0 引用数: 0
h-index: 0
机构: NCI, Bethesda, MD 20892 USA

Carter, W
论文数: 0 引用数: 0
h-index: 0
机构: NCI, Bethesda, MD 20892 USA

Hoppe, R
论文数: 0 引用数: 0
h-index: 0
机构: NCI, Bethesda, MD 20892 USA

Canellos, GP
论文数: 0 引用数: 0
h-index: 0
机构: NCI, Bethesda, MD 20892 USA
[7]
SUMOylation plays a role in gemcitabine- and bortezomib-induced cytotoxicity in human oropharyngeal carcinoma KB gemcitabine-resistant clone
[J].
Chung, V
;
Zhou, B
;
Liu, XY
;
Zhu, L
;
Boo, LM
;
Nguyen, HV
;
Ann, DK
;
Song, J
;
Chen, Y
;
Yen, Y
.
MOLECULAR CANCER THERAPEUTICS,
2006, 5 (03)
:533-540

Chung, V
论文数: 0 引用数: 0
h-index: 0
机构: City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA

Zhou, B
论文数: 0 引用数: 0
h-index: 0
机构: City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA

Liu, XY
论文数: 0 引用数: 0
h-index: 0
机构: City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA

Zhu, L
论文数: 0 引用数: 0
h-index: 0
机构: City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA

Boo, LM
论文数: 0 引用数: 0
h-index: 0
机构: City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA

Nguyen, HV
论文数: 0 引用数: 0
h-index: 0
机构: City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA

Ann, DK
论文数: 0 引用数: 0
h-index: 0
机构: City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA

Song, J
论文数: 0 引用数: 0
h-index: 0
机构: City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA

Chen, Y
论文数: 0 引用数: 0
h-index: 0
机构: City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA

Yen, Y
论文数: 0 引用数: 0
h-index: 0
机构: City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA
[8]
Proteasome inhibition sensitizes non-small-cell lung cancer to gemcitabine-induced apoptosis
[J].
Denlinger, CE
;
Rundall, BK
;
Keller, MD
;
Jones, DR
.
ANNALS OF THORACIC SURGERY,
2004, 78 (04)
:1207-1214

Denlinger, CE
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Virginia, Dept Thorac & Cardiovasc Surg, Charlottesville, VA 22908 USA Univ Virginia, Dept Thorac & Cardiovasc Surg, Charlottesville, VA 22908 USA

Rundall, BK
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Virginia, Dept Thorac & Cardiovasc Surg, Charlottesville, VA 22908 USA Univ Virginia, Dept Thorac & Cardiovasc Surg, Charlottesville, VA 22908 USA

Keller, MD
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Virginia, Dept Thorac & Cardiovasc Surg, Charlottesville, VA 22908 USA Univ Virginia, Dept Thorac & Cardiovasc Surg, Charlottesville, VA 22908 USA

Jones, DR
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Virginia, Dept Thorac & Cardiovasc Surg, Charlottesville, VA 22908 USA Univ Virginia, Dept Thorac & Cardiovasc Surg, Charlottesville, VA 22908 USA
[9]
Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease
[J].
Diehl, V
;
Franklin, J
;
Pfreundschuh, M
;
Lathan, B
;
Paulus, U
;
Hasenclever, D
;
Tesch, H
;
Herrmann, R
;
Dörken, B
;
Müller-Hermelink, H
;
Dühmke, E
;
Loeffler, M
.
NEW ENGLAND JOURNAL OF MEDICINE,
2003, 348 (24)
:2386-2395

Diehl, V
论文数: 0 引用数: 0
h-index: 0
机构: Univ Cologne, Innere Med Klin 1, Dept Internal Med 1, D-50924 Cologne, Germany

Franklin, J
论文数: 0 引用数: 0
h-index: 0
机构: Univ Cologne, Innere Med Klin 1, Dept Internal Med 1, D-50924 Cologne, Germany

Pfreundschuh, M
论文数: 0 引用数: 0
h-index: 0
机构: Univ Cologne, Innere Med Klin 1, Dept Internal Med 1, D-50924 Cologne, Germany

Lathan, B
论文数: 0 引用数: 0
h-index: 0
机构: Univ Cologne, Innere Med Klin 1, Dept Internal Med 1, D-50924 Cologne, Germany

Paulus, U
论文数: 0 引用数: 0
h-index: 0
机构: Univ Cologne, Innere Med Klin 1, Dept Internal Med 1, D-50924 Cologne, Germany

Hasenclever, D
论文数: 0 引用数: 0
h-index: 0
机构: Univ Cologne, Innere Med Klin 1, Dept Internal Med 1, D-50924 Cologne, Germany

Tesch, H
论文数: 0 引用数: 0
h-index: 0
机构: Univ Cologne, Innere Med Klin 1, Dept Internal Med 1, D-50924 Cologne, Germany

Herrmann, R
论文数: 0 引用数: 0
h-index: 0
机构: Univ Cologne, Innere Med Klin 1, Dept Internal Med 1, D-50924 Cologne, Germany

Dörken, B
论文数: 0 引用数: 0
h-index: 0
机构: Univ Cologne, Innere Med Klin 1, Dept Internal Med 1, D-50924 Cologne, Germany

Müller-Hermelink, H
论文数: 0 引用数: 0
h-index: 0
机构: Univ Cologne, Innere Med Klin 1, Dept Internal Med 1, D-50924 Cologne, Germany

Dühmke, E
论文数: 0 引用数: 0
h-index: 0
机构: Univ Cologne, Innere Med Klin 1, Dept Internal Med 1, D-50924 Cologne, Germany

Loeffler, M
论文数: 0 引用数: 0
h-index: 0
机构: Univ Cologne, Innere Med Klin 1, Dept Internal Med 1, D-50924 Cologne, Germany
[10]
Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: Report of an intergroup trial
[J].
Duggan, DB
;
Petroni, GR
;
Johnson, JL
;
Glick, JH
;
Fisher, RI
;
Connors, JM
;
Canellos, GP
;
Peterson, BA
.
JOURNAL OF CLINICAL ONCOLOGY,
2003, 21 (04)
:607-614

Duggan, DB
论文数: 0 引用数: 0
h-index: 0
机构: SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA

Petroni, GR
论文数: 0 引用数: 0
h-index: 0
机构: SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA

Johnson, JL
论文数: 0 引用数: 0
h-index: 0
机构: SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA

Glick, JH
论文数: 0 引用数: 0
h-index: 0
机构: SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA

Fisher, RI
论文数: 0 引用数: 0
h-index: 0
机构: SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA

Connors, JM
论文数: 0 引用数: 0
h-index: 0
机构: SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA

Canellos, GP
论文数: 0 引用数: 0
h-index: 0
机构: SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA

Peterson, BA
论文数: 0 引用数: 0
h-index: 0
机构: SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA